We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Noninvasive Device Computes Blood Glucose Levels

By LabMedica International staff writers
Posted on 13 Sep 2010
Raman spectroscopy has been used to measure the amount of glucose in the tissue under the skin without the need to perform phlebotomy. More...


Raman spectroscopy is a technique used to study vibrational, rotational, and other low-frequency modes in a system. It relies on inelastic scattering of monochromatic light, usually from a laser in the visible, near infrared, or near ultraviolet range.

Patients undergoing the oral glucose tolerance test (OGTT) need to have their blood drawn at frequent intervals so that after ingestion of a glucose-rich solution, the level of glucose in the blood can be estimated. This test will determine how quickly glucose is cleared from the blood, an indicator of diabetes, insulin resistance, or reactive hypoglycemia. In a study of 10 healthy volunteers undergoing OGTT, at the Massachusetts Institute of Technology's (MIT) Spectroscopy Laboratory (Cambridge, MA, USA), blood concentrations of glucose were measured every 10 minutes using a clinical glucose analyzer (HemoCue, Inc., Lake Forest, CA, USA).

Raman spectra were collected every five minutes from the forearms of healthy Caucasian and Asian human volunteers undergoing the OGTT. For the excitation source, an 830 nm diode laser was used at an average power of 300 mW on a 1 mm2 skin spot. An f/1.8 spectrograph was coupled to a liquid nitrogen-cooled charge-coupled device for spectral dispersion and acquisition, respectively. A dynamic concentration correction (DCC) calibration method was applied to the Raman spectra results for correlation with the blood glucose results.

The Raman technique actually measures the glucose concentration in the interstitial fluid and not the blood. However, this calibration becomes more difficult immediately after the patient drinks the glucose solution because blood glucose soars rapidly, while it takes 5-10 minutes to see a corresponding surge in the interstitial fluid glucose levels. Therefore, interstitial fluid measurements do not give an accurate picture of what is happening in the bloodstream. To compare the two sets of results, the scientists used an algorithm that relates the two concentrations, allowing them to predict blood glucose levels from the glucose concentration in interstitial fluid. After the algorithm was applied, the results from the two sets of data were very similar.

The scientists reported that using DCC-calibrated Raman spectroscopy significantly boost the accuracy of blood glucose measurements with an average improvement of 15%, and up to 30% in some subjects. The study was published in the June 2010 issue of Analytical Chemistry.

Related Links:
Massachusetts Institute of Technology
HemoCue, Inc.



Platinum Member
ADAMTS-13 Protease Activity Test
ATS-13 Activity Assay
Verification Panels for Assay Development & QC
Seroconversion Panels
POCT Fluorescent Immunoassay Analyzer
FIA Go
Gold Member
Turbidimetric Control
D-Dimer Turbidimetric Control
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.